These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27459346)

  • 1. Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study.
    Grignolo S; Bruzzone B; Gabbi L; Gerbaldo D; Gallo F; Nigro N; Icardi G; Viscoli C; Di Biagio A
    Virulence; 2017 Jan; 8(1):101-108. PubMed ID: 27459346
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy.
    Sheth PM; Kovacs C; Kemal KS; Jones RB; Raboud JM; Pilon R; la Porte C; Ostrowski M; Loutfy M; Burger H; Weiser B; Kaul R;
    AIDS; 2009 Sep; 23(15):2050-4. PubMed ID: 19710596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twelve-Month Antiretroviral Therapy Suppresses Plasma and Genital Viral Loads but Fails to Alter Genital Levels of Cytokines, in a Cohort of HIV-Infected Rwandan Women.
    Ondoa P; Gautam R; Rusine J; Lutter R; Jurriaans S; Kootstra N; Karita E; van de Wijgert J
    PLoS One; 2015; 10(5):e0127201. PubMed ID: 26010956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
    Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
    AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral adherence and development of drug resistance are the strongest predictors of genital HIV-1 shedding among women initiating treatment.
    Graham SM; Masese L; Gitau R; Jalalian-Lechak Z; Richardson BA; Peshu N; Mandaliya K; Kiarie JN; Jaoko W; Ndinya-Achola J; Overbaugh J; McClelland RS
    J Infect Dis; 2010 Nov; 202(10):1538-42. PubMed ID: 20923373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol consumption and HIV-1 vaginal RNA shedding among women.
    Theall KP; Amedee A; Clark RA; Dumestre J; Kissinger P
    J Stud Alcohol Drugs; 2008 May; 69(3):454-8. PubMed ID: 18432389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-DNA in the genital tract of women on long-term effective therapy is associated to residual viremia and previous AIDS-defining illnesses.
    Prazuck T; Chaillon A; Avettand-Fènoël V; Caplan AL; Sayang C; Guigon A; Niang M; Barin F; Rouzioux C; Hocqueloux L
    PLoS One; 2013; 8(8):e69686. PubMed ID: 23990886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micronutrient supplementation increases genital tract shedding of HIV-1 in women: results of a randomized trial.
    McClelland RS; Baeten JM; Overbaugh J; Richardson BA; Mandaliya K; Emery S; Lavreys L; Ndinya-Achola JO; Bankson DD; Bwayo JJ; Kreiss JK
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1657-63. PubMed ID: 15577425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 RNA shedding in the female genital tract is associated with reduced quantity of Lactobacilli in clinically asymptomatic HIV-positive women.
    Mane A; Kulkarni S; Ghate M; Risbud A; Thakar M
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):112-4. PubMed ID: 23142167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina.
    Mostad SB; Overbaugh J; DeVange DM; Welch MJ; Chohan B; Mandaliya K; Nyange P; Martin HL; Ndinya-Achola J; Bwayo JJ; Kreiss JK
    Lancet; 1997 Sep; 350(9082):922-7. PubMed ID: 9314871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy.
    Masese LN; Graham SM; Gitau R; Peshu N; Jaoko W; Ndinya-Achola JO; Mandaliya K; Richardson BA; Overbaugh J; McClelland RS
    BMC Infect Dis; 2011 Nov; 11():307. PubMed ID: 22047086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
    Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
    AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment interruptions predict female genital shedding of genotypically resistant HIV-1 RNA.
    Graham SM; Jalalian-Lechak Z; Shafi J; Chohan V; Deya RW; Jaoko W; Mandaliya KN; Peshu NM; Overbaugh J; McClelland RS
    J Acquir Immune Defic Syndr; 2012 Aug; 60(5):511-8. PubMed ID: 22592588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-associated genital tract virus and vertical transmission of human immunodeficiency virus type 1 in antiretroviral-experienced women.
    Tuomala RE; O'Driscoll PT; Bremer JW; Jennings C; Xu C; Read JS; Matzen E; Landay A; Zorrilla C; Blattner W; Charurat M; Anderson DJ;
    J Infect Dis; 2003 Feb; 187(3):375-84. PubMed ID: 12552421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.
    Wang CC; McClelland RS; Reilly M; Overbaugh J; Emery SR; Mandaliya K; Chohan B; Ndinya-Achola J; Bwayo J; Kreiss JK
    J Infect Dis; 2001 Apr; 183(7):1017-22. PubMed ID: 11237825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium deficiency is associated with shedding of HIV-1--infected cells in the female genital tract.
    Baeten JM; Mostad SB; Hughes MP; Overbaugh J; Bankson DD; Mandaliya K; Ndinya-Achola JO; Bwayo JJ; Kreiss JK
    J Acquir Immune Defic Syndr; 2001 Apr; 26(4):360-4. PubMed ID: 11317079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women.
    Saracino A; Di Stefano M; Fiore JR; Lepera A; Raimondi D; Angarano G; Pastore G
    New Microbiol; 2000 Jan; 23(1):79-83. PubMed ID: 10946409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital tract leukocytes and shedding of genital HIV type 1 RNA.
    Anderson BL; Wang CC; Delong AK; Liu T; Kojic EM; Kurpewski J; Ingersoll J; Mayer K; Caliendo AM; Cu-Uvin S
    Clin Infect Dis; 2008 Nov; 47(9):1216-21. PubMed ID: 18808359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV genital shedding and safety of Carraguard use by HIV-infected women: a crossover trial in Thailand.
    McLean CA; van de Wijgert JH; Jones HE; Karon JM; McNicoll JM; Whitehead SJ; Braunstein S; Achalapong J; Chaikummao S; Tappero JW; Markowitz LE; Kilmarx PH
    AIDS; 2010 Mar; 24(5):717-22. PubMed ID: 20098295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.